Clinical trial monitoring evaluations and measurements
DISEASE, PATHOLOGY
From the medical chart (paper or electronic) this additional data was collected: age, gender, weight, pathology report, steroid and other medication doses over the course of treatment, ChemoID test results, MGMT gene methylation status, IDH-1 mutation status, chemotherapy regimens including doses, all brain imaging including but not limited to DICOM images of MRI and or CT scans, clinical assessment of disease at baseline and during the course of therapy from neuro-oncologic progress notes, Health-Related Quality of Life (HRQOL) questionnaires addressing physical, psychological, emotional, and social issues.